Special Issue "Casting Light on Cancer Therapy"
Deadline for manuscript submissions: closed (31 March 2015).
Interests: high intensity laser nuclear and particle physics and applications with particular reference to proton oncology; high intensity laser ionization and fragmentation of molecules and applications with particular reference to laser detection of explosives and other environmentally sensitive materials; coupling of high intensity lasers with accelerators with particular reference to Thomson back scattering
For about sixty years it has been known that proton and heavy ion therapy is a very powerful radiation procedure for treating tumors. It has an innate ability to irradiate tumors with greater doses and spatial selectivity compared with electron and photon therapy and, hence, is a tissue sparing procedure.
For more than twenty years powerful lasers have generated high energy beams of protons and heavy ions and, therefore, it has frequently been speculated that lasers could be used as an alternative to RF accelerators to produce the particle beams necessary for cancer therapy. This Special Issue reviews the progress made towards laser driven hadron cancer therapy and what has still to be accomplished to realize its inherent enormous potential.
Before the implementation of therapy, however, there are many necessary areas of essential development and we would especially be interested in receiving submissions covering the following and allied areas of research:
(a) the development of reduced size high power lasers for proton and ion therapy;
(b) identifying the laser parameters necessary to produce protons and ions suitable for cancer treatment;
(c) laser-produced monochromatic X-rays for diagnostics;
(d) laser and target technology for producing monoenergetic ion beams;
(e) transport and focusing of laser driven ion beams;
(f) radiobiology and cell damage studies using laser-produced proton beams;
(g) laser-driven medical isotope production, particularly PET isotope production;
(h) medical applications with laser-accelerated electron beams;
(i) advances in diagnostic techniques to characterise and control laser produced ion and photon beams;
(j) critical comparison of conventional and anticipated laser accelerators for producing secondary sources suitable for medical applications;
(k) reports on the establishment of mixed teams of clinicians, radiologists, tissue biologists and chemists to promote the aims of this area of research.
Prof. Dr. Ken Ledingham
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Applied Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- laser driven ion beams
- laser driven electron beams
- laser ion targetry
- control of laser driven ion beams
- laser driven ion tissue interaction
- radiation shielding
- proton therapy
- cancer therapy